481 related articles for article (PubMed ID: 23208712)
1. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
3. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
[TBL] [Abstract][Full Text] [Related]
4. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
[TBL] [Abstract][Full Text] [Related]
5. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
6. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
8. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
9. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
[TBL] [Abstract][Full Text] [Related]
10. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice.
Ferrari S; Sanguinetti M; De Bernardis F; Torelli R; Posteraro B; Vandeputte P; Sanglard D
Antimicrob Agents Chemother; 2011 May; 55(5):1852-60. PubMed ID: 21321146
[TBL] [Abstract][Full Text] [Related]
11. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.
Ferrari S; Ischer F; Calabrese D; Posteraro B; Sanguinetti M; Fadda G; Rohde B; Bauser C; Bader O; Sanglard D
PLoS Pathog; 2009 Jan; 5(1):e1000268. PubMed ID: 19148266
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
[TBL] [Abstract][Full Text] [Related]
13. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
14. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
Torelli R; Posteraro B; Ferrari S; La Sorda M; Fadda G; Sanglard D; Sanguinetti M
Mol Microbiol; 2008 Apr; 68(1):186-201. PubMed ID: 18312269
[TBL] [Abstract][Full Text] [Related]
15. Milbemycin A4 oxime as a probe of azole transport in Candida glabrata.
Walker B; Izumikawa K; Tsai HF; Bennett JE
FEMS Yeast Res; 2014 Aug; 14(5):755-61. PubMed ID: 24838041
[TBL] [Abstract][Full Text] [Related]
16. Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata.
Kumari S; Kumar M; Esquivel BD; Wasi M; Pandey AK; Kumar Khandelwal N; Mondal AK; White TC; Prasad R; Gaur NA
mBio; 2022 Feb; 13(1):e0354521. PubMed ID: 35038899
[TBL] [Abstract][Full Text] [Related]
17. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
18. Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
Moirangthem R; Kumar K; Kaur R
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722894
[TBL] [Abstract][Full Text] [Related]
19. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
